We have investigated the potential of rocuronium 0.6 mg kg 91 (2 ED 95 ) and 0.9 mg kg 91 (3 ED 95 ) for rapid sequence induction in 100 children, aged 3-7 yr. Intubating conditions with the two different doses of rocuronium were assessed in 70 children (n:35 in each group) undergoing elective surgery. Intubation was carried out by mimicking rapid sequence induction, and intubation conditions were evaluated according to a standard score. Intubating conditions were good to excellent in all 70 patients investigated (2 ED 95 : excellent 29, good 6; 3 ED 95 : excellent 33, good 2). In another 30 children (n:15 in each group), we examined the times of rocuronium-induced neuromuscular block using electromyography. Lag time and recovery index did not differ significantly between the two groups (lag time: 37 (SD 12) vs 33 (14) s; recovery index: 9 (3) vs 10 (4) min). . The rapid onset of action of rocuronium was the subject of several investigations determining if this compound allows rapid sequence induction. In adult patients, good to excellent intubating conditions were reported [3] [4] [5] . Crul and colleagues found that increasing the dose of rocuronium from 0.6 to 0.9 mg kg 91 improved conditions for rapid sequence induction 6 . Unfortunately they did not provide any information on whether or not this increase changed the time course of neuromuscular block, a well known phenomenon with other neuromuscular blockers 7 . In four of 40 patients undergoing elective Caesarean section, Abouleish and colleagues found clinically unacceptable intubating conditions after administration of rocuronium 0.6 mg kg 91 8
) for rapid sequence induction in 100 children, aged 3-7 yr. Intubating conditions with the two different doses of rocuronium were assessed in 70 children (n:35 in each group) undergoing elective surgery. Intubation was carried out by mimicking rapid sequence induction, and intubation conditions were evaluated according to a standard score. Intubating conditions were good to excellent in all 70 patients investigated (2 ED 95 : excellent 29, good 6; 3 ED 95 : excellent 33, good 2). In another 30 children (n:15 in each group), we examined the times of rocuronium-induced neuromuscular block using electromyography. Lag time and recovery index did not differ significantly between the two groups (lag time: 37 (SD 12) vs 33 (14) s; recovery index: 9 (3) vs 10 (4) min). Three times the ED 95 Rocuronium bromide is a new steroidal nondepolarizing neuromuscular blocking drug, related structurally to vecuronium. This compound is characterized by a rapid onset and intermediate duration of neuromuscular block 1 2 . The rapid onset of action of rocuronium was the subject of several investigations determining if this compound allows rapid sequence induction. In adult patients, good to excellent intubating conditions were reported [3] [4] [5] . Crul and colleagues found that increasing the dose of rocuronium from 0.6 to 0.9 mg kg 91 improved conditions for rapid sequence induction 6 . Unfortunately they did not provide any information on whether or not this increase changed the time course of neuromuscular block, a well known phenomenon with other neuromuscular blockers 7 . In four of 40 patients undergoing elective Caesarean section, Abouleish and colleagues found clinically unacceptable intubating conditions after administration of rocuronium 0.6 mg kg 91 8 . Thus, this suggests that 2 ED95 of rocuronium is not sufficient for rapid sequence induction. The only published study using rocuronium for intubation in children was reported by Woelfel and co-workers 9 . However, the use of rocuronium in children for rapid sequence induction has not been evaluated to date. This question is of clinical interest because of the recent controversy on the use of suxamethonium in children 10 11 . The aim of this study was to investigate intubating conditions with two different doses of rocuronium (0.6 and 0.9 mg kg 91 ) in children. Intubating conditions were investigated by mimicking rapid sequence induction. In addition, we assessed the time course of rocuronium-induced neuromuscular block.
Patients and methods
The study was approved by the institutional Ethics Committee and informed consent was obtained from the children's parents. We studied 100 children, ASA I or II, aged 3-7 yr, undergoing elective surgery. Patients were excluded if they were known to have neuromuscular disease or were receiving medications known to influence neuromuscular function. All patients were premedicated with midazolam 0.2 mg kg 91 orally, 1 h before induction of anaesthesia. We first assessed the quality of rocuronium neuromuscular block in the context of rapid sequence induction. Seventy patients were allocated randomly to one of two groups of 35, to receive either rocuronium 0.6 mg kg 91 (2 ED95) or 0.9 mg kg 91 (3 ED95). Anaesthesia was induced with alfentanil 10 g kg 91 and thiopentone 5 mg kg 91 followed by the dose of rocuronium according to patient group. Rocuronium was injected over 5 s. Sixty seconds after the end of injection, the trachea was intubated in all patients by the same experienced anaesthetist blinded to the treatment. He assessed intubating conditions using the following criteria Correspondence to T. F.-B.
immobile, and no diaphragmatic movement; good:jaw relaxed, vocal cords abducted and immobile, and some diaphragmatic movement; poor:jaw relaxed, vocal cords moving, and coughing; and inadequate:jaw not relaxed and vocal cords closed Cricoid pressure was applied during insertion of the tube. In addition, intubation time (time from start of intubation until definitive placement of the oral tube) was determined in both groups.
In the second part of the study we investigated the time course of rocuronium-induced neuromuscular block, comparing doses of 2 ED95 with 3 ED95. Thirty children were allocated randomly to one of two groups of 15. In both groups anaesthesia was induced with alfentanil 10 g kg 91 and thiopentone 5 mg kg
91
, and maintained with isoflurane (1% end-tidal concentration) and 60% nitrous oxide in oxygen via a face mask. End-tidal carbon dioxide concentration was maintained at 4.5-5 vol% (Normocap, Datex Instrumentarium Corporation, Finland). Neuromuscular transmission was assessed by electromyography (Relaxograph, Datex Instrumentarium Corporation, Finland) at the right ulnar nerve-hypothenar muscle using transcutaneous electrodes. Measurements started when anaesthesia had been induced. The Relaxograph was set to deliver supramaximal stimuli (0.1 ms duration) of train-offour (TOF) at 2 Hz every 20 s. The first of the four evoked responses was considered the twitch height. To minimize movement-induced changes in twitch response during electromyography, the patient's hand was fixed carefully. When the end-tidal isoflurane concentration had stabilized, the Relaxograph was re-calibrated and control twitch height measured. Patients then received either rocuronium 0.6 or 0.9 mg kg
. Administration of rocuronium was synchronized with the Relaxograph, with completion of injection concomitantly at the end of control TOF stimulation. The following times of neuromuscular block were measured: lag time:time between administration of rocuronium and the first measurable neuromuscular effect (twitch depression ജ5% of control value); twitch height at 1 min:twitch height 1 min after administration of rocuronium; onset time:time between administration of rocuronium and maximum twitch depression; clinical duration (CD):time between administration of rocuronium and recovery to 25% twitch height; recovery index (RI):time from 25% to 75% twitch height recovery; and duration 75 (D75):time between administration of rocuronium and recovery to 75% twitch height.
End-tidal carbon dioxide concentration, temperature over the adductor pollicis muscle and isoflurane concentration were maintained stable during the whole study (4.5-5 vol%, ജ35 ЊC and 0.8-1%, respectively). Patients did not receive additional neuromuscular blockers until recovery to 95<5% twitch height. Patients in whom twitch height did not recover to control levels were excluded.
The Mann-Whitney U test was used for statistical comparison of the times of neuromuscular block induced by the two different doses of rocuronium. Intubating conditions were analysed using the chi-square test. All values, except intubation scores, are expressed as mean (SD). For statistical comparisons, differences were considered significant when P:0.05.
Results
The study groups did not differ in age or weight (table 1) .
Intubating conditions obtained with both rocuronium 2 ED95 and 3 ED95 were clinically acceptable (e.g. excellent or good) (table 2). There were no differences in the frequency distribution of excellent or good intubation conditions between the two groups: after 2 ED95, intubating conditions were excellent in 29 patients and good in six; after 3 ED95, intubating conditions were excellent in 33 patients and good in two. Intubation was performed within 12.5 (3.4) s after 2 ED95 and within 11.6 (2.7) s after 3 ED95. The doses of drugs used for rapid sequence induction were comparable in both groups (table 3) ; respectively).
After rocuronium, twitch height recovered to control levels in all 30 patients included in this part of the study. Lag time did not differ between the two doses (37 (12) Recovery index was similar in both groups: 9 (3) min after 2 ED95 and 10 (4) min after 3 ED95 (table 4) .
Discussion
We have investigated for the first time the potential of rocuronium for rapid sequence induction in children. The doses of rocuronium represented 2 ED95 and 3 ED95 for this age group 9 . The most important finding was that after both rocuronium 2 ED95 (0.6 mg kg
91
) and 3 ED95 (0.9 mg kg 91 ), intubating conditions evaluated at 60 s after administration of the neuromuscular blocking agent were good to excellent (table 2) .
There is some controversy on whether or not measurement of end-points such as onset time is meaningful in the context of defining optimal intubating conditions. Agoston stated that "onset time has become overestimated as a predictive parameter for the rate of development of adequate intubating conditions", and "is not a meaningful, quantifiable end-point defining optimal intubating conditions" 12 . Conversely, Magorian, Flannery and Miller "have chosen to monitor twitch tension as an end-point defining optimal intubating conditions, because this technique is quantifiable and reliable" 3 . Intubation score is the principal measure in the context of rapid sequence induction, as it indicates whether or not the patient's airway can be adequately secured reliably. Measurement of the time course of neuromuscular block is also important because information on onset characteristics (e.g. lag time, twitch height at 1 min and onset time) are complementary to information provided by the intubation score. However, both intubating conditions and time course of neuromuscular block are influenced by the depth of anaesthesia 8 13 . To overcome this problem in the context of measurement of the time course of neuromuscular block, re-calibration of the Relaxograph is needed when steady state concentration of the volatile anaesthetic is achieved. Any additional change in inspired concentration may directly influence the results 14 thus compromising the relevance of the data. With regard to intubating conditions, only those drugs needed for rapid sequence induction should be given, with no drug supplement before the tracheal tube is inserted and intubating conditions scored 15 .
We evaluated both intubation score and times of rocuronium-induced neuromuscular block. In order to overcome the methodological problem described, we evaluated intubating conditions and neuromuscular pharmacodynamics in separate groups of patients.
Thus in the first part of the study we investigated the potential of rocuronium for rapid sequence induction, using it strictly according to the scenario for rapid sequence induction but in elective cases. Factors affecting intubation conditions, such as the dose of hypnotic 16 or opioid
, and clinical practice in our institution which limits suxamethonium to paediatric emergencies, we dismissed this possibility. In our opinion, these two drugs should be compared in children undergoing emergency intubation, where the use of suxamethonium is generally accepted.
To date, there are few data available on intubating conditions with rocuronium in paediatric patients. In a study of 12 children, intubating conditions 60 s after rocuronium were found to be excellent in nine and good in three patients 9 . Unfortunately the authors did not provide information on the potential of rocuronium for rapid sequence intubation, as intubating conditions were evaluated under steady state halothane anaesthesia. In adults, there is one published investigation on the potential of rocuronium for emergency intubation, using it strictly according to the scenario for rapid sequence induction but still in elective cases 6 . These authors found a higher frequency of excellent intubating conditions when the dose of rocuronium was increased from 0.6 to 0.9 mg kg 91 . They concluded that the higher dose of rocuronium should be used for "real" rapid sequence induction. This conclusion was supported indirectly by the results of Abouleish and colleagues who found in four of 40 patients undergoing Caesarean section poor or inadequate intubation conditions 60 s after rocuronium 0.6 mg kg 91 8 .
In the second part of this study, we measured the time course of neuromuscular block after rocuronium 0.6 and 0.9 mg kg 91 in children. Particular attention was given to assessing the onset characteristics of rocuronium. These were assessed measuring lag time, twitch height at 1 min and onset time. In a study in adult patients, Wierda and colleagues 18 found that the lag time of rocuronium was less than that of vecuronium; neuromuscular block was initiated in less than 40 s, which is important in situations where rapid control of the airway is required. However, in this study, an increase in the dose of rocuronium from 0.6 to 0.9 mg kg 91 did not lead to further acceleration of lag time. In addition, the initial progression of rocuronium-induced neuromuscular block was fast, leading to advanced motor block 1 min after injection of rocuronium, at the moment when rapid sequence intubation takes place. This phenomenon was more pronounced after the higher dose. In contrast with these findings, the onset time of rocuronium was not particularly fast in our patients. This confirms the findings of Wierda and colleagues who reported that rocuronium has an onset time comparable with that of vecuronium 18 . It is the rapid initial development of neuromuscular block which distinguishes rocuronium from other non-depolarizing neuromuscular blocking agents, and this may explain the favourable intubating conditions observed.
The duration of action of rocuronium was found to be intermediate after both 0.6 and 0.9 mg kg 91 (table  4) . Increasing the dose of rocuronium also increased its duration of action. This increase was statistically significant, but should not be clinically relevant as the profile of the drug did not change. Moreover, the recovery index was not affected by the increase in dose. These results are in accordance with those reported in the same age group by Woelfel and colleagues 9 . We conclude that in children, rocuronium at both doses investigated offered good to excellent intubating conditions for rapid sequence induction in elective patients. Whether or not the intubating conditions of either rocuronium 0.6 or 0.9 mg kg 91 are comparable with those of suxamethonium should be investigated in real emergency situations.
